Blood-labyrinth barrier damage mediated by granzymes from cytotoxic lymphocytes results in hearing loss in systemic lupus erythematosus
- PMID: 40794837
- DOI: 10.1073/pnas.2423240122
Blood-labyrinth barrier damage mediated by granzymes from cytotoxic lymphocytes results in hearing loss in systemic lupus erythematosus
Abstract
Hearing loss (HL) in patients with systemic lupus erythematosus (SLE) has been widely reported, though the underlying mechanisms remain unclear. In this study, we demonstrate significant HL in an imiquimod-induced mouse model of SLE, accompanied by blood-labyrinth barrier (BLB) damage in the stria vascularis (SV). We found that cytotoxic CD8+ T lymphocytes and natural killer cells mediate BLB disruption, with granzyme b (Gzmb) acting as the primary factor inducing cell death of the cochlear capillary endothelial cells. Remarkably, inhibiting Gzmb by Serpinb9 significantly alleviates the elevations of hearing thresholds in imiquimod-induced SLE model mice, suggesting a therapeutic target for autoimmune-related HL. Our findings provide insights into the pathogenesis of SLE-related HL and propose Gzmb inhibition as a potential therapeutic strategy.
Keywords: blood–labyrinth barrier; granzymes; hearing loss; immune-mediated cytotoxicity; systemic lupus erythematosus.
Conflict of interest statement
Competing interests statement:The authors declare no competing interest.
Similar articles
-
Studying the biology of cytotoxic T lymphocytes in vivo with a fluorescent granzyme B-mTFP knock-in mouse.Elife. 2020 Jul 22;9:e58065. doi: 10.7554/eLife.58065. Elife. 2020. PMID: 32696761 Free PMC article.
-
Intestinal inflammation and microbiota modulation impact cochlear function: emerging insights in gut-ear axis.Cell Commun Signal. 2025 Jul 26;23(1):357. doi: 10.1186/s12964-025-02338-1. Cell Commun Signal. 2025. PMID: 40713718 Free PMC article.
-
Dysregulation in keratinocytes drives systemic lupus erythematosus onset.Cell Mol Immunol. 2025 Jan;22(1):83-96. doi: 10.1038/s41423-024-01240-z. Epub 2024 Dec 3. Cell Mol Immunol. 2025. PMID: 39627610
-
Autologous hematopoietic stem cell transplantation in Systemic Lupus Erythematosus and antiphospholipid syndrome: A systematic review.Autoimmun Rev. 2017 May;16(5):469-477. doi: 10.1016/j.autrev.2017.03.008. Epub 2017 Mar 7. Autoimmun Rev. 2017. PMID: 28279836
-
Risk factors for cardiovascular diseases in patients with systemic lupus erythematosus: an umbrella review.Clin Rheumatol. 2023 Nov;42(11):2931-2941. doi: 10.1007/s10067-023-06608-6. Epub 2023 May 5. Clin Rheumatol. 2023. PMID: 37142864
MeSH terms
Substances
Grants and funding
- 81970884/MOST | National Natural Science Foundation of China (NSFC)
- 82192862/MOST | National Natural Science Foundation of China (NSFC)
- 82171136/MOST | National Natural Science Foundation of China (NSFC)
- 92368110/MOST | National Natural Science Foundation of China (NSFC)
- 82371156/MOST | National Natural Science Foundation of China (NSFC)
- 82171145/MOST | National Natural Science Foundation of China (NSFC)
- 82101223/MOST | National Natural Science Foundation of China (NSFC)
- BK20241726/JST | Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation)
- 82201286/MOST | National Natural Science Foundation of China (NSFC)
LinkOut - more resources
Full Text Sources
Medical
Research Materials